PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Cormica Banner Ad – 24.02.2025
Novo Nordisk 20 March 2024, 11:21
Biosynth: Fri 4 October 2024, 10:42

Excessive Prices in the Pharma Sector: The EU Antitrust Perspective

An undertaking is defined as dominant if it enjoys such a significant market position as to grant it the power to behave, to an appreciable extent, independently of competitors, customers and ultimately consumers. This dominance lays a special responsibility on the undertaking not to hinder competition in the market. Sara Lembo at BonelliErede examines how the Treaty on the Functioning of the European Union (TFEU) prohibits a dominant undertaking from directly or indirectly imposing unfair prices.

 

Stoelzle Skyscraper: 27th November 2024
Chemspec Europe – 27.02.2025
PHARMAP: Mon 14 October 2024, 10.36
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35